Summary
Updated Aug 30, 2026
Stephen C. Glover is Director of ONCOLYTICS BIOTECH INC (ONCY). 4 SEC Form 4 filings on record going back to 2025, most recently on 3 June 2026.
Trading Pattern
InsiderAlpha's records for Stephen C. Glover go back to 2025: 4 primary Form 4 filings, an average of 2.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Stephen C. Glover files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Bernd R. Seizinger - $187K of ONCY open-market activity in the last 12 months
- Jared Kelly - $34K of ONCY open-market activity in the last 12 months
- Patricia S. Andrews - $30K of ONCY open-market activity in the last 12 months
- Andrew Aromando - $25K of ONCY open-market activity in the last 12 months
- Wayne Pisano - $25K of ONCY open-market activity in the last 12 months
- Deborah Margaret Brown - $21K of ONCY open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Stephen C. Glover?
Stephen C. Glover is a corporate insider, tracked as Director of ONCOLYTICS BIOTECH INC (ONCY). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Stephen C. Glover submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Stephen C. Glover's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Stephen C. Glover and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial